title: Deal watch: Roles and strategies for health foundations in public-private partnerships.
authors.affiliation: TI Pharma, PO Box 142 2300 AC Leiden, The Netherlands, at the time of the study.
authors.forename: Remco L
authors.initials: RL
authors.lastname: de Vrueh
authors.affiliation: TI Pharma, PO Box 142 2300 AC Leiden, The Netherlands, at the time of the study.
authors.forename: Waseem
authors.initials: W
authors.lastname: Awad
authors.affiliation: TI Pharma, PO Box 142 2300 AC Leiden, The Netherlands, at the time of the study.
authors.forename: Anne
authors.initials: A
authors.lastname: Stolk
authors.affiliation: TI Pharma, PO Box 142 2300 AC Leiden, The Netherlands, at the time of the study.
authors.forename: Fred A
authors.initials: FA
authors.lastname: Dijcks
authors.affiliation: TI Pharma, PO Box 142 2300 AC Leiden, The Netherlands, at the time of the study.
authors.forename: Ton W M
authors.initials: TW
authors.lastname: Rijnders
authors.affiliation: TI Pharma, PO Box 142 2300 AC Leiden, The Netherlands, at the time of the study.
authors.forename: Jorg W
authors.initials: JW
authors.lastname: Janssen
mesh_terms: D015195:Drug Design; D055808:Drug Discovery / Q000191:economics; D015507:Drugs, Investigational / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D005582:Foundations / Q000191:economics; D006801:Humans; D018803:Models, Economic; D055818:Public-Private Sector Partnerships / Q000191:economics; D012109:Research Support as Topic; D057170:Translational Research, Biomedical / Q000191:economics; D014837:Voluntary Health Agencies / Q000191:economics
chemical_list: D015507:Drugs, Investigational